Predictors for readmission of acute ischemic stroke in Taiwan

Journal of the Formosan Medical Association

Volumn 110, Issue 10, 2011, Pages 627-633

  Li, Hsuan Wei ^a,b   Yang, Ming Chin ^a   Chung, Kuo Piao ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b MINISTRY OF NATIONAL DEFENSE   (Taiwan)

Author keywords

Evidence based practice guidelines; Ischemic stroke; Patterns of care; Readmission

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT;

AGE; AGED; ARTICLE; BRAIN ISCHEMIA; DIABETES MELLITUS; EVIDENCE BASED PRACTICE; FEMALE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRACTICE GUIDELINE; PRESCRIPTION; RETROSPECTIVE STUDY; SURVIVOR; TAIWAN;

AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; DIABETES MELLITUS; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT READMISSION; PLATELET AGGREGATION INHIBITORS; RECURRENCE; STROKE; TAIWAN;

EID: 80054033865     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/j.jfma.2011.08.004     Document Type: Article

References (28)

1. Chuang K.Y., Wu S.C., Yeh M.C., Chen Y.H., Wu C.L. Exploring the associations between long-term care and mortality r ates among stroke patients. J Nurs Res 2005, 13:117-127.
2. Lee A.H., Yau K.K., Wang K. Recurrent ischemic stroke hospitalizations: a retrospective cohort study using Western Australia linked patient records. Eur J Epidemiol 2004, 19:999-1003.
3. Chuang K.Y., Wu S.C., Ma A.H., Chen Y.H., Wu C.L. Identifying factors associated with hospital readmissions among stroke patients in Taipei. J Nurs Res 2005, 13:117-127.
4. Andersen H.E., Schultz-Larsen K., Kreiner S., Forchhammer B.H., Eriksen K., Brown A. Can readmission after stroke be prevented? Results of a randomized clinical study: a postdischarge follow-up service for stroke survivors. Stroke 2000, 31:1038-1045.
5. Westert G.P., Lagoe R.J., Keskimäki I., Leyland A., Murphy M. An international study of hospital readmissions and related utilization in Europe and the USA. Health Policy 2002, 61:269-278.
6. Bravata D.M., Ho S.Y., Meehan T.P., Brass L.M., Concato J. Readmission and death after hospitalization for acute ischemic stroke. 5-year follow-up in the Medicare population. Stroke 2007, 38:1899-1904.
7. Ottenbacher K.J., Smith P.M., Illig S.B., Linn R.T., Fiedler R.C., Granger C.V. Comparison of logistic regression and neural networks to predict rehospitalization in patients with stroke. J Clin Epidemiol 2001, 54:1159-1165.
8. Johansen H.L., Wielgosz A.T., Nguyen K., Fry R.N. Incidence, comorbidity, case fatality and readmission of hospitalized stroke patients in Canada. Can J Cardiol 2006, 22:65-71.
9. Xu G., Liu X., Wu W., Zhang R., Yin Q. Recurrence after ischemic stroke in Chinese patients: impact of uncontrolled modifiable risk factors. Cerebrovasc Dis 2007, 23:117-120.
10. Lee Y.Y., Lin K.L., Wang H.S., Chou M.L., Hung P.C., Hsieh M.Y., et al. Risk factors and outcomes of childhood ischemic stroke in Taiwan. Brain Dev 2008, 30:14-19.
11. Stroke and transient ischaemic attacks: assessment, investigation, immediate management and secondary prevention 2003, Available from:, [accessed 25.05.06]. http://www.guideline.gov/browse/browsecondition.aspx.
12. Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the America Stroke Association (a division of the American Heart Association) 2002, Available from:, [accessed 25.05.06]. http://www.guideline.gov/browse/browsecondition.aspx.
13. Diagnosis and initial treatment of ischemic stroke 2005, Available from:, [accessed 25.05.06]. http://www.guideline.gov/browse/browsecondition.aspx.
14. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombotic Therapy 2004, Available from:, [accessed 25.05.06]. http://www.guideline.gov/browse/browsecondition.aspx.
15. Tissue plasminogen activator (t-PA) for acute ischemic stroke 2002, Available from:, [accessed 25.05.06]. http://www.guideline.gov/browse/browsecondition.aspx.
16. Taiwan Stroke Society. Guideline. Available from: ; 2008 [accessed 25.05.09] [in Chinese]. http://www.stroke.org.tw/guideline/guideline_index.asp.
17. Adams H.P. Emergent use of anticoagulation for treatment of patients with ischemic stroke. Stroke 2002, 33:856-861.
18. Tseng M.C., Lin H.J. Readmission after hospitalization for stroke in Taiwan: results from a national sample. J Neurol Sci 2009, 284:52-55.
19. Kennedy B.S. Does race predict stroke readmission? An analysis using the truncated negative binomial model. J Natl Med Assoc 2005, 97:699-713.
20. Toyoda K., Okada Y., Kobayashi S. Early recurrence of ischemic stroke in Japanese patients: the Japan standard stroke registry study. Cerebrovasc Dis 2007, 24:289-295.
21. Bohannon R.W., Lee N. Association of physical functioning with same-hospital readmission after stroke. Am J Phys Med Rehab 2004, 83:434-438.
22. Claesson L., Gosman-Hedström G., Fagerberg B., Blomstrand C. Hospital re-admissions in relation to acute stroke unit care versus conventional care in elderly patients the first year after stroke: the Goteborg 70+ stroke study. Age Ageing 2003, 32:109-113.
23. Bayley M., Lindsay P., Hellings C., Woodbury E., Phillips S. Balancing evidence and opinion in stroke care: the 2008 best practice recommendations. Can Med Assoc J 2008, 179:1247-1249.
24. Arif H., Aijaz B., Islam M., Aftab U., Kumar S., Shafqat S. Drug compliance after stroke and myocardial infarction: a comparative study. Neurol India 2007, 55:130-135.
25. Aronow H.D., Califf R.M., Harrington R.A., Vallee M., Graffagnino C., Shuaib A., et al. Relation between aspirin dose, all-cause mortality, and bleeding in patients with recent cerebrovascular or coronary ischemic events (from the BRAVO trail). Am J Cardiol 2008, 102:1285-1290.
26. Sacco R.L., Diener H.C., Yusuf S., Cotton D., Ounpuu S., Lawton W.A., et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008, 359:1238-1251.
27. Shinohara Y., Gotoh F., Tohgi H., Hirai S., Terashi A., Fukuuchi Y., et al. Antiplatelet cilostazol is beneficial in diabetic and/or hypertension ischemic stroke patients. Cerebrovasc Dis 2008, 26:63-70.
28. Cha J.K., Jeon H.W., Kang M.J. ADP-induced platelet aggregation in acute ischemic stroke patients on aspirin therapy. Eur J Neurol 2008, 15:1304-1308.